NEWS & MEDIA

News Archive

Press Release – Marketing Alliance with Agena Bioscience

Press Release – Marketing Alliance with Agena Bioscience

Agena Bioscience and HeartGenetics Enter Marketing Alliance   HeartGenetics and Agena Bioscience announced today a co-promotion agreement leveraging Agena’s MassARRAY®…

[read more]
HeartGenetics will attend the ISIN congress in Madrid

HeartGenetics will attend the ISIN congress in Madrid

It’s with great pleasure that HeartGenetics will participate in the 10th anniversary of the International Symposium on Immunonutrition in Madrid…

[read more]
HeartGenetics launches new test in Oncology  – OncoAlvo®

HeartGenetics launches new test in Oncology – OncoAlvo®

(versão em Português em baixo)  HeartGenetics continues to increase its portfolio of genetic tests, particularly within the pharmacogenetics area. OncoAlvo®…

[read more]
Workshop em Oncologia – 16 de Dezembro

Workshop em Oncologia – 16 de Dezembro

A HeartGenetics, em parceria com o IPO-Porto, está a organizar um workshop em Oncologia. Consulte em baixo mais informações.    …

[read more]
HeartGenetics is at Web Summit this week

HeartGenetics is at Web Summit this week

HEARTGENETICS is at Web Summit this week. HEARTGENETICS was chosen one of 66 startups to represent Portugal at Web Summit…

[read more]
HeartGenetics finalist of the EIT Health InnoStars GoEurope 2016 Awards

HeartGenetics finalist of the EIT Health InnoStars GoEurope 2016 Awards

HeartGenetics is excited to announce that is finalist of the EIT Health InnoStars GoEurope 2016 Award with the project “Digital…

[read more]
DNArterialDECODER

DNArterialDECODER

HeartGenetics in cooperation with CHUC (Centro Hospitalar e Universitário de Coimbra), has developed the DNArterialDECODER project. This project seeks to…

[read more]
New partnership – Umut Biotech

New partnership – Umut Biotech

HeartGenetics is proud to announce its new partnership with Umut Biotech, who will serve as a new distributor for HeartGenetics’…

[read more]
New approved P2020 project – Forward2Future

New approved P2020 project – Forward2Future

HeartGenetics’ project, Forward2Future, promotes an increase in the company’s competitiveness, flexibility and capacity to respond to the ever increasing demands…

[read more]
New P2020 project approved: OncoAlvo

New P2020 project approved: OncoAlvo

HeartGenetics, in cooperation with IPO Porto, started the development of research project OncoAlvo, a project focused on Optimizing Technological Innovations…

[read more]